I found this one premarket but by then it was .34 cents and I wanted it at .38 but had to get in at .39 dropped out at .46 ... I actually bought less shares than I wanted on accident by typing.
[TimAlerts]
ARGS - Argos Therapeutics announces the the independent data monitoring committee for its Phase 3 ADAPT clinical trial of AGS-003 for the treatment of metastatic renal cell carcinoma has recommended the continuation of the trial
Join now or log in to leave a comment